[HTML][HTML] APOL1-associated end-stage renal disease in a living kidney transplant donor

NA Zwang, A Shetty, N Sustento-Reodica… - American Journal of …, 2016 - Elsevier
Homozygosity for apolipoprotein-L1 (APOL1) risk variants has emerged as an important
predictor of renal disease in individuals of African descent over the past several years.
Additionally, these risk variants may be important predictors of renal allograft failure when
present in a living or deceased donor. Currently, there is no universal recommendation for
screening of potential donors. We present a case of end-stage renal disease with focal
segmental glomerulosclerosis in a living donor 7 years following donor nephrectomy …